Streetbeat News

Earnings

CROX

LYFT

REGN

SBUX

Insiders at Starbucks, Regeneron Pharmaceuticals, Crocs, and Lyft have recently sold shares. These sales come amidst various company performances, including better-than-expected financial results for Crocs and Regeneron Pharmaceuticals, and a revenue miss for Starbucks. Insider sales can indicate various strategic decisions or perspectives on the company's stock value.

Portfolio Pulse from Avi Kapoor

February 20, 2024 | 12:59 pm

IRBT

LEG

SONY

The article highlights four consumer discretionary stocks considered oversold based on their Relative Strength Index (RSI) values being near or below 30. These stocks include iRobot Corporation (IRBT), Leggett & Platt, Incorporated (LEG), LL Flooring Holdings, Inc. (LL), and Sony Group Corporation (SONY). Each company's recent financial performance and stock price actions are discussed, indicating potential undervaluation and opportunity for investors.

Portfolio Pulse from Avi Kapoor

February 20, 2024 | 12:44 pm

DFS

GFS

INTC

NVDA

SSRM

WMT

US stocks are poised for a weaker open influenced by mixed retail earnings, with Home Depot reporting a sales decline and Walmart rising after acquiring VIZIO and posting solid results. Nvidia's upcoming earnings are highly anticipated, given its expected AI-driven growth. Last week's inflation reports led to a market pullback, ending a five-week winning streak for major indices. Discover Financial surged in premarket trading after an acquisition announcement, while GLOBALFOUNDRIES and Intel saw gains from government subsidies. SSR Mining's stock fell due to a temporary suspension of search and rescue activities.

Portfolio Pulse from Shanthi Rexaline

February 20, 2024 | 12:40 pm

Home Depot Inc (NYSE:HD) reported a Q4 FY23 sales decline of 2.9% year-on-year to $34.79 billion, surpassing analyst estimates. EPS was $2.82, beating the consensus of $2.77. Despite these beats, the stock price declined. The company saw a decrease in customer transactions and comparable sales. Operating income fell 12.8% to $4.1 billion, with operating expenses up 2.7%. Home Depot announced a 7.7% dividend increase to $2.25 per share. For 2024, it forecasts a 1% sales growth and EPS growth, slightly below consensus estimates. Analysts have a positive outlook, with an average 12-month price target of $374.0.

Portfolio Pulse from Anusuya Lahiri

February 20, 2024 | 12:35 pm

WMT

Walmart's stock is trading higher following the announcement of their Q4 financial results, which surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:35 pm

ESGR

Enstar Group (ESGR) reported a significant increase in its Q4 earnings per share (EPS) to $39.71, up 199.47% from $13.26 YoY. Sales also surged to $482M, marking a 161.96% increase from $184M YoY.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:35 pm

ZCAR

Zoomcar Holdings, Inc. (NASDAQ:ZCAR) shares dropped over 7% in premarket trading after announcing a partnership with SPARKCARS to add over 1,000 electric vehicles to its platform in India. Despite a 19% decrease in net revenue to $2.4 million in the third quarter, Zoomcar projects a significant revenue increase for the calendar year ending December 31, 2024, and expects to achieve a positive adjusted EBITDA run rate.

Portfolio Pulse from Nabaparna Bhattacharya

February 20, 2024 | 12:27 pm

CRNT

Ceragon Networks projects its 2024 revenue to be between $385M and $405M, indicating an 11% to 17% growth from 2023, factoring in contributions from its recent acquisition of Siklu in December 2023. The company also targets non-GAAP operating margins of at least 10% and anticipates increased non-GAAP profit along with positive free cash flow for the full year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:21 pm

CRNT

Ceragon Networks (NASDAQ:CRNT) reported Q4 adjusted EPS of $0.04, surpassing the $0.03 estimate, with sales of $90.36M exceeding the $84.78M estimate, marking a 19.63% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:19 pm

BCYC

Bicycle Therapeutics reported a Q4 EPS of $(1.16), a decrease from $(1.01) YoY, and sales of $5.33M, missing the $7.14M estimate.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:13 pm